Geraldine Villanueva-Rodríguez

Suggest Changes
Learn More
PURPOSE This randomized phase II trial evaluated whether the combination of cisplatin and paclitaxel (PC) plus all-trans retinoic acid (ATRA) increases response rate (RR) and progression-free(More)
A frequent manifestation of advanced NSCLC is malnutrition, even though there are many studies which relate it with a poor survival, its relation with toxicity has not yet been consistently reported.(More)
Oscar Arrieta ( Rosa Mayela Michel Ortega ( Geraldine Villanueva-Rodríguez ( Maria Guadalupe Serna-Thomé (
  • 1